Lv1
30 积分 2024-03-03 加入
Pharmacokinetics, Bioequivalence, and Safety Evaluation of 2 Formulations of 10‐mg Rivaroxaban Tablets: A 4‐Period Crossover Trial
2天前
已完结
Physiologically-based pharmacokinetic modeling to predict drug-drug interaction of enzalutamide with combined P-gp and CYP3A substrates
2天前
已关闭
Effect of a High‐Fat Diet on the Pharmacokinetics and Safety of Rivaroxaban in Healthy Chinese Subjects
2天前
已完结
Apixaban and rivaroxaban's physiologically‐based pharmacokinetic model validation in hospitalized patients: A first step for larger use of a priori modeling approach at bed side
2天前
已完结
The Pharmacogenetic Variability Associated With the Pharmacokinetics and Pharmacodynamics of Rivaroxaban in Healthy Chinese Subjects: A National Multicenter Exploratory Study
2天前
已完结
Pharmacokinetics of single‐dose rivaroxaban under fed state in obese vs. non‐obese subjects: An open‐label controlled clinical trial (RIVOBESE‐PK)
2天前
已完结
ABCG2 polymorphism and rivaroxaban pharmacokinetics in healthy individuals after a single dose
2天前
已完结
In vitro assessment of the risk of ABCB1-mediated drug–drug interaction between rivaroxaban and tacrolimus in human embryonic kidney 293 recombinant cell lines
2天前
已完结
Warfarin–Amiodarone Drug–Drug Interactions: Determination of [I]u/KI,u for Amiodarone and Its Plasma Metabolites
17天前
已完结
皖公网安备34019202002308
